D. Fingar
Molecular Biology · 2002–2012
A researcher in the Science corpus: 7 papers; trusts 6 researchers and is trusted by 18 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 177 citations into it; #2,531 of 17,773 by trust here, #2,983 by citations
- Physiology — 63 citations into it; #337 of 2,276 by trust here, #646 by citations
Whom D. Fingar trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Lewis C. Cantley
- K. Inoki
- A. Gingras
- B. Manning
- Guangchao Sui
- S. Hawley
- D. Hardie
- R. Weinberg
- D. Hanahan
- William C. Hahn
Who trusts D. Fingar overall
- A. Budanov
- K. Inoki
- Jingxiang Huang
- M. Karin
- Marina K. Holz
- B. Manning
- J. Blenis
- D. Munn
- N. Hay
- L. Bar-Peled
Papers from D. Fingar's perspective
Ordered by how strongly the researchers D. Fingar trusts endorse each paper. Same corpus, a different order for every researcher.
- TSC2 mediates cellular energy response to control cell growth and survival. (Cell)
- Regulation of cellular growth by the Drosophila target of rapamycin dTOR. (Genes & Development)
- Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. (Molecules and Cells)
- Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR (Proceedings of the National Academy of Sciences of the United States of America)
- Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. (Cell)
- The Mammalian Target of Rapamycin (mTOR) Partner, Raptor, Binds the mTOR Substrates p70 S6 Kinase and 4E-BP1 through Their TOR Signaling (TOS) Motif* (Journal of Biological Chemistry)
- Role of AMP-activated protein kinase in mechanism of metformin action. (Journal of Clinical Investigation)
- Mammalian TOR: A Homeostatic ATP Sensor (Science)
- A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. (Cancer Research)
- A DNA vector-based RNAi technology to suppress gene expression in mammalian cells (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. (2002) — 1,118 citations
- Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression (2004) — 1,302 citations
- Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling (2002) — 850 citations
- mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E (2004) — 903 citations
- Molecular interpretation of ERK signal duration by immediate early gene products (2002) — 1,006 citations
- Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. (2012) — 980 citations
- Guidelines for the use and interpretation of assays for monitoring autophagy (2012) — 4,856 citations